Greentrail Capital is a global technology investment firm founded in 2020 and headquartered in London. It invests in both public and private growth-stage technology companies, focusing on disruptive technology and high-growth industries across fintech, enterprise software, marketplaces, and digital infrastructure.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (50% of deals). Average disclosed round size is $90.0M (across 5 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Alvar Fernández, CFA
Partner & Equity Analyst
Malcolm Geddes
Partner
Aleksander Baranski
Investor
Arnau Porto Dolc
Chief Investment Officer
Tom Lovik
Investor
Sergey Glazyrin, CFA
Co-CEO & Co-CIO | Portfolio Manager
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 finn | Seed | $110M | May 2022 |
 Terray | Series A | $60M | Feb 2022 |
 Terray Therapeutics | Series A | $60M | Feb 2022 |
 FINN | Series B | $110M | Jan 2022 |
| finn | Unknown | $110M | Jan 2022 |
| Terray Therapeutics | Series A | — | Jan 2021 |
Top Co-Investors
Last updated: 7 October 2026